Abstract
Context-specific signaling is a prevalent theme in cancer biology wherein individual molecules and pathways can have multiple or even opposite effects depending on the tumor type. TAK1 represents a particularly notable example of such signaling diversity in cancer progression. Originally discovered as a TGF-β-activated kinase, over the years it has been shown to respond to numerous other stimuli to phosphorylate a wide range of downstream targets and elicit distinct cellular responses across cell and tissue types. Here we present a comprehensive review of TAK1 signaling and provide important therapeutic perspectives related to its function in different cancers.
Original language | English (US) |
---|---|
Pages (from-to) | 1402-1413 |
Number of pages | 12 |
Journal | Oncogene |
Volume | 39 |
Issue number | 7 |
DOIs | |
State | Published - Feb 13 2020 |
ASJC Scopus subject areas
- Molecular Biology
- Genetics
- Cancer Research